Former Van Halen and Montrose frontman Sammy Hagar is leading a group of other musicians in a campaign to get the Food and Drug Administration to approve an experimental treatment for a friend’s brain cancer.
Hagar and friends sent a letter to FDA’s Center for Drug Evaluation and Research and Sammy asked the agency to allow Liza Cozad-Lauser to have access to “an experimental treatment involving the use of antineoplastons.”
An online petition has also been created to help bring awareness to Liza’s condition: PETITION
Below is the letter sent by Hagar and some of his influential rocker friends in hopes that the FDA will allow her to be in control of her own decisions for her own life. Let’s hope some others will jump into the middle of this.
According to the American Cancer Society, the treatment has been around for more than 40 years, but “there is no convincing evidence showing that antineoplastons actually work.” In the article from www.cancer.org it also states that “No randomized controlled trials showing the effectiveness of antineoplastons have been published in the peer-reviewed scientific literature”.
There is only one clinic in the United States, in Houston, where patients are allowed to participate in clinical trials led by a doctor named Stanislaw Burzynski. Proponents claim antineoplaston therapy has been successful in treating many forms of cancer. They claim people with cancer don’t have enough naturally occurring antineoplastons and that this therapy replenishes the body’s supply, allowing the biochemical defense system of the body to induce cancer cells to stop growing and to develop features that resemble normal cells (cell differentiation).
Cozad-Lauser is the wife of Hagar’s drummer, David Lauser, and the other signatories on the letter share the heavy metal connection: Van Halen drummer Michael Anthony; bassist Jack Blades of Night Ranger and guitarist Joe Satriani, who has played with a range of bands including Deep Purple.
But Hagar and pals argue that medical treatment is a personal choice:
“We are aware there are differences of opinion within the medical community regarding the efficacy and potential of antineoplastons in treating patients afflicted with this illness,” they write. “We are not asking the FDA to take a side in this debate. We are writing to simply urge that Liza be allowed to receive the treatment she seeks while research on the potential of antineoplastons for potential widespread use continues.”
Antineoplaston therapy was developed by Stanislaw Burzynski, MD, PhD. Initial treatments are given over the course of 1 – 3 weeks at a clinic in Houston, founded by Dr. Burzynski. Further treatments might be given at home, but could require monthly visits to a doctor. In the past, many of the patients who received antineoplaston treatment were also treated with surgery, radiation, chemotherapy, or combinations of these standard treatments at other centers before visiting Dr. Burzynski’s clinic. Some patients also received chemotherapy or radiation prescribed by Dr. Burzynski.
Currently, antineoplaston treatment is available in the United States only through participation in clinical trials led by Dr. Burzynski and his colleagues. Patients cannot receive conventional anti-cancer treatment from other doctors while they are taking part in these antineoplaston studies.